Larvol Delta - VAY2EXPLORE-A-Study-to-Assess-the-Tolerability-of-Ianalumab-VAY736-With-Investigator39s-Choice-Thrombopoietin-Receptor-Agonist-IC-TPORA-in-Patients-With-Primary-Immune-Thrombocytopenia-ITP

Doptelet (avatrombopag) - SOBI

Nplate (romiplostim) - Amgen

Promacta (eltrombopag) - Novartis

ianalumab (VAY736) - Novartis

http://clinicaltrials.gov/ct2/show/NCT07421167

Sep 19, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next